Article courtesy of Andrew McConaghie PMLive

The deadlock between pharmaceutical company Vertex and NHS England over the cystic fibrosis drug Orkambi was played out in a parliamentary hearing in London on 7th March, when the company’s CEO Jeff Leiden and NHS England and NICE leaders were grilled by MPs.

Read the full article here: